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We investigated 2 fatal cases of Rocky Mountain spot-
ted fever that occurred in 2003 and 2004 near the same 
locality in Colombia where the disease was ﬁ  rst reported 
in the 1930s. A retrospective serosurvey of febrile patients 
showed that >21% of the serum samples had antibodies 
against spotted fever group rickettsiae.
B
etween July 1934 and August 1936, sixty-ﬁ  ve cases 
of Rocky Mountain spotted fever (RMSF), 62 of them 
fatal, were reported from Tobia, Colombia (1). No reports 
of this disease (known locally as Fiebre de Tobia) have 
been produced from Colombia since, and currently RMSF 
is generally not included in the differential diagnoses of 
febrile syndromes.
We recently conﬁ  rmed RMSF as the cause of death 
for 2 patients by PCR (2,3), sequencing, immunohisto-
chemical tests (4), and culture (5) (Table 1). The ﬁ  rst pa-
tient was a 32-year-old pregnant woman (26 weeks), who 
had abdominal pain, headache, and fever in December 
2003; pharyngitis was diagnosed, and she received amox-
icillin with no improvement. A cutaneous macular rash, 
hepatomegaly, hyperbilirubinemia, leukocytosis, and 
thrombocytopenia (50,000/μL) subsequently developed. 
She then experienced respiratory failure and died. One of 
her relatives, as well as 2 dogs, had died a few days earlier 
with similar symptoms. Another sick dog rapidly recov-
ered after receiving doxycycline. 
The second patient was a 31-year-old previously healthy 
man who went to the local hospital in May 2004 with fe-
ver and severe headache; dengue was diagnosed clinically. 
Three days later, he became stuporous and was admitted to 
the hospital. Within a short period, seizures developed and 
he became comatose. He died a few hours later. 
The 2 patients lived near the towns of Villeta and To-
bia, Cundinamarca, Colombia. The histopathologic ﬁ  ndings 
of both patients were similar and consisted of vascular con-
gestion; interstitial edema; frequent nonoccluding thrombi 
(mainly in the lungs); and multiple foci of perivascular lym-
phocytic and monocytic inﬁ  ltration in all viscera, includ-
ing the brain. The lungs showed marked interstitial inﬂ  am-
matory inﬁ   ltrates. Immunohistochemical analysis showed 
rickettsiae in the microvascular endothelium of all studied 
organs, including brain, liver, spleen, and lungs of both 
patients (Figure). 
Several weeks after these events, we collected and 
identiﬁ  ed adult male and female ticks from the farms and 
surroundings where the patients had lived (Table 1). We 
found ticks of the species Amblyomma cajennense, a known 
vector of spotted fever group rickettsioses in Latin America 
(6–9), and Rhipicephalus sanguineus, recently documented 
as a vector for Rickettsia rickettsii (10).
To begin to clarify the magnitude of spotted fever 
group rickettsioses as a public health problem in Colombia, 
we tested the following samples for spotted fever group 
rickettsiae by immunoﬂ  uorescence assay (IFA) (11): 1) 
64 serum samples from a national Colombian surveillance 
system (2001–2004) that studies malaria, dengue, and yel-
low fever (Instituto Nacional de Salud, Colombia); and 2) 
96 serum samples from a regional (the state where the re-
ported patients lived) surveillance system (2000–2001) for 
dengue (Secretaria de Salud de Cundinamarca, Colombia). 
Serum samples showing distinctly ﬂ  uorescent rickettsiae at 
a >1:64 dilution were considered positive. We found im-
munoglobulin G (IgG) and IgM antibodies against spotted 
fever group rickettsiae (R. rickettsii was used as antigen) 
but not against typhus group rickettsiae (R. typhi was used 
as antigen) (Table 2). These data suggest that spotted fever 
group rickettsioses may be a frequent cause of febrile ill-
nesses, not only in the state where the reported patients lived 
but also in various other regions of Colombia. Since there is 
strong cross-reactivity among rickettsial species when IFA 
is used as an antibody-detection technique, other spotted 
fever group rickettsiae, including those recently described 
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Figure. Immunohistochemical analysis shows the presence of 
spotted fever group rickettsiae (brown) in vessels of brain of a patient 
with fatal Rocky Mountain spotted fever (magniﬁ  cation 400).Rocky Mountain Spotted Fever, Colombia
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in Latin America (R. parkeri and R. felis) could explain the 
assay results (12,13). Furthermore, most of these patients 
received a clinical diagnosis of dengue, an endemic disease 
in Colombia that appears to have become an umbrella di-
agnosis under which other diseases are assigned. A similar 
situation was recently described in Mexico (14).
RMSF in Colombia is seldom considered in the dif-
ferential diagnosis for febrile disease; possible causes in-
clude the lack of an adequate diagnostic infrastructure and 
the invisibility of tick- and ﬂ  eaborne infectious diseases in 
most medical curricula. The problem is further compound-
ed by the presence of numerous agents (many transmitted 
by arthropod vectors) that produce nonspeciﬁ  c febrile syn-
dromes during the early stages of the disease. Most of those 
agents are viruses that, unlike rickettsiae, have no speciﬁ  c 
treatment; thus, physicians might not feel compelled to use 
antimicrobial agents. Given the lack of appropriate and in-
expensive diagnostic tests that are useful in the acute stage 
and that can be implemented in small rural hospitals, the 
best diagnostic tool available to healthcare personnel is 
clinical suspicion based on knowledge of the clinical mani-
festations (15), ecology, and epidemiology of rickettsio-
ses. Physicians in areas where RMSF is endemic should 
consider prescribing a course of empirical treatment with 
doxycycline in patients who have high fever, severe head-
ache, and myalgia, even in the absence of rash or history 
of tick bite, as both are frequently absent in RMSF. Such a 
treatment will not harm a patient with dengue or other viral 
infections and is likely to save the life of a patient infected 
with R. rickettsii.
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Table 1. Rocky Mountain spotted fever patients and findings, Colombia, 2003–2004 
Confirmatory methods 
Patient PCR Sequence IHA*
Animal
inoculation Culture
Adult ticks collected in 
area where patients 
lived
Genes Primers
Homology with 
Rickettsia rickettsii
1
17-kDa 17kD1/2 100% (Sheila Smith) 
Positive with 
rabbit anti–
spotted fever 
group
rickettsial 
antibody 
Not done  Not done  15 Amblyomma 
cajennense, 184
Rhipicephalus
sanguineus, 7
Anocentor nitens, and
8 Amblyomma spp. 
Genes Primers
Homology with  
R. rickettsii
gltA CS78/323 99% (Bitterroot and 
others)
gltA CS5/6 94% (Bitterroot) 
OmpA 190.70/701 98% (strain 1995HO2 
and others) 
2
OmpB rOmpB.20-2788 98%  (GenBank 
accession no. 
X16353.1)
Positive with 
rabbit anti–
spotted fever 
group
rickettsial 
antibody 
24 h and 48 h 
after fever 
onset, 2 guinea 
pigs were 
euthanized for 
culture and PCR 
analysis of 
spleens
Vero cells 
with 
cytopathic 
changes
after 1 week 
36 A. cajennense, 13
R. sanguineus, and 38
Boophilus microplus
*Immunohistochemical analysis. 
Table 2.Titers of antibodies to spotted fever group rickettsiae (antigen: Rickettsia rickettsii) by indirect immunofluorescence antibody 
assay* 
IgG IgM
Surveillance
program† 
No.
tested
No. (%) 
positive Titer n
No. (%) 
positive Titer n
No. also positive 
for IgG  States of origin 
National 64 3 (4.7)  128 1 1 (1.5)  512 1 0
256 2
Santander,
Guaviare, Caldas
Regional 96 21 (21.9)  64 3 20 (20.8)  64 3 Cundinamarca
128 10 128 4
256 4 256 9 10
512 3 512 3
1,024 1 1,024 1
*Ig, immunoglobulin. 
†Acute Febrile Disease Surveillance Programs. DISPATCHES
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